Clinical Trials Logo

Shoulder Tendinopathy clinical trials

View clinical trials related to Shoulder Tendinopathy.

Filter by:
  • None
  • Page 1

NCT ID: NCT06241404 Completed - Clinical trials for Shoulder Tendinopathy

Efficacy of Therapeutic Exercise vs. Treatment of Myofascial Trigger Points.

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

Background: Shoulder pain commonly affects the general population, with rotator cuff tendinopathy being the most common cause. the most common cause, with rotator cuff tendinopathy diminishing function and quality of life, leading to a major socio-economic impact. quality of life, leading to a major socio-economic impact. As a result, there are two treatment approaches with potential effectiveness: therapeutic exercise (TE) and myofascial trigger point treatment (TMT). trigger point treatment (TTP). Objective: The main objective of this randomised clinical trial is to determine the efficacy of ET versus treatment of MTPs in shoulder tendinopathies. Methods: For this study, 20 participants were randomly divided into two groups: a ET group, with which a 10-exercise programme was initiated (n = 10), and a PGM group which was given an intervention protocol (n = 10). intervention protocol (n = 10). Both received a total of 10 sessions. Pain intensity pain intensity, pressure pain threshold (PPT) and range of motion (ROM) were assessed before starting and after 10 sessions. and after 10 sessions.

NCT ID: NCT04636528 Completed - Clinical trials for Musculoskeletal Pain

Digital Versus Conventional Physical Therapy for Chronic Shoulder Tendinopathy

Start date: August 4, 2021
Phase: N/A
Study type: Interventional

This is a single-center, prospective, randomised, controlled study, with two parallel groups, designed to assess the clinical impact of a digital exercise program against conventional rehabilitation for shoulder tendonitis. The hypothesis is that all the clinical outcomes measured will significantly improve after the program, and patients using this novel system will attain at least the same outcomes than the ones attained by the conventional PT group.